Welcome to the REVEAL Study website

The REVEAL study is an international clinical trial that aims to find out if treating cholesterol with a new drug called anacetrapib will drive down the risk of heart attacks, deaths from heart disease and other vascular diseases.

What does the REVEAL study involve?

Who is responsible for the REVEAL study?

The study is being coordinated by the Clinical Trial Service Unit (CTSU) at Oxford University.

Further Information

Click here for the REVEAL press release of 02 September 2013

In the meantime, if you would like further information, please contact us on 0800 585323 or email reveal@ctsu.ox.ac.uk